Wird geladen...
Neuroimaging Biomarkers for Alzheimer’s Disease
Currently, over five million Americans suffer with Alzheimer’s disease (AD). In the absence of a cure, this number could increase to 13.8 million by 2050. A critical goal of biomedical research is to establish indicators of AD during the preclinical stage (i.e. biomarkers) allowing for early diagnos...
Gespeichert in:
| Veröffentlicht in: | Mol Neurodegener |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6555939/ https://ncbi.nlm.nih.gov/pubmed/31174557 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13024-019-0325-5 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|